Logo image of USNA

USANA HEALTH SCIENCES INC (USNA) Stock Price, Forecast & Analysis

USA - New York Stock Exchange - NYSE:USNA - US90328M1071 - Common Stock

21.93 USD
+0.33 (+1.53%)
Last: 1/16/2026, 8:04:00 PM
21.93 USD
0 (0%)
After Hours: 1/16/2026, 8:04:00 PM

USNA Key Statistics, Chart & Performance

Key Statistics
Market Cap400.88M
Revenue(TTM)912.67M
Net Income(TTM)16.99M
Shares18.28M
Float10.42M
52 Week High38.32
52 Week Low18.48
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)1.96
PE11.19
Fwd PE11.03
Earnings (Next)04-20
IPO1993-10-28
Sector
GICS SectorConsumer Staples
GICS IndustryPersonal Care Products
GICS IndustryGroupHousehold & Personal Products
GICS SubIndustryPersonal Care Products
USNA short term performance overview.The bars show the price performance of USNA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20

USNA long term performance overview.The bars show the price performance of USNA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of USNA is 21.93 USD. In the past month the price increased by 7.08%. In the past year, price decreased by -35.54%.

USANA HEALTH SCIENCES INC / USNA Daily stock chart

USNA Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to USNA. When comparing the yearly performance of all stocks, USNA is a bad performer in the overall market: 83.17% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

USNA Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to USNA. USNA has an excellent financial health rating, but there are some minor concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

USNA Financial Highlights

Over the last trailing twelve months USNA reported a non-GAAP Earnings per Share(EPS) of 1.96. The EPS decreased by -30.74% compared to the year before.


Industry RankSector Rank
PM (TTM) 1.86%
ROA 2.34%
ROE 3.22%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-126.79%
Sales Q2Q%6.88%
EPS 1Y (TTM)-30.74%
Revenue 1Y (TTM)5.88%

USNA Forecast & Estimates

6 analysts have analysed USNA and the average price target is 39.78 USD. This implies a price increase of 81.4% is expected in the next year compared to the current price of 21.93.

For the next year, analysts expect an EPS growth of -31.74% and a revenue growth 8.25% for USNA


Analysts
Analysts43.33
Price Target39.78 (81.4%)
EPS Next Y-31.74%
Revenue Next Year8.25%

USNA Ownership

Ownership
Inst Owners61.98%
Ins Owners0.6%
Short Float %5.61%
Short Ratio2.25

About USNA

Company Profile

USNA logo image USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,700 full-time employees. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.

Company Info

USANA HEALTH SCIENCES INC

3838 West Parkway Blvd.

Salt Lake City UTAH 84120 US

CEO: Kevin G. Guest

Employees: 1700

USNA Company Website

USNA Investor Relations

Phone: 18019547100

USANA HEALTH SCIENCES INC / USNA FAQ

What does USNA do?

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,700 full-time employees. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.


Can you provide the latest stock price for USANA HEALTH SCIENCES INC?

The current stock price of USNA is 21.93 USD. The price increased by 1.53% in the last trading session.


What is the dividend status of USANA HEALTH SCIENCES INC?

USNA does not pay a dividend.


How is the ChartMill rating for USANA HEALTH SCIENCES INC?

USNA has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Is USANA HEALTH SCIENCES INC (USNA) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on USNA.


Can you provide the market cap for USANA HEALTH SCIENCES INC?

USANA HEALTH SCIENCES INC (USNA) has a market capitalization of 400.88M USD. This makes USNA a Small Cap stock.


Can you provide the ownership details for USNA stock?

You can find the ownership structure of USANA HEALTH SCIENCES INC (USNA) on the Ownership tab.